A new study published in the journal “Case Reports in Oncology,” published by the National Institute of Health. found that cannabis can treat some forms of acute lymphoblastic leukemia, a cancer of the white blood cells.
The study reads in part, “Acute lymphoblastic leukemia is a cancer of the white blood cells and is typically well treated with combination chemotherapy, with a remission state after 5 years of 94% in children and 30-40% in adults. This case study was on a 14-year-old patient diagnosed with a very aggressive form. A standard bone marrow transplant, aggressive chemotherapy and radiation therapy were revoked, with treatment being deemed a failure after 34 months.”
Without any other solutions provided by conventional approaches aside from palliation, the family administered cannabinoid extracts orally to the patient. Cannabinoid resin extract was used as an effective treatment with a positive Philadelphia chromosome mutation and indications of dose-dependent disease control.
Researchers concluded that, “The clinical observation in this study revealed a rapid dose-dependent correlation”, indicating that the higher the dose, the better the results.
The study can be viewed by visiting ncbi.nlm.nih.gov.